# Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer

> **NCT05843292** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 48 (estimated)

## Conditions studied

- Triple-negative Breast Cancer

## Interventions

- **DRUG:** Taxane and Carboplatin
- **DRUG:** Short-term Sintilimab
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT05843292
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2034-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2023-06-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05843292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05843292, "Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05843292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*